Hyliion is trading at $3.16 (-5.11%); no clear catalyst explains the August 24 decline.

  • No new company-specific announcement or filing clearly explains the move; latest identifiable developments remain positive Q2 results and a $41.7 million U.S. Navy contract.
  • Broader markets are mixed: the S&P 500 is down 0.23% and Nasdaq is down 0.44%, neither exceeding the requested 0.5% threshold.